glutathione and multiple myeloma A recent editorial describes the science behind a study of mezigdomide, which augments the degradation of the proteins Ikaros Aiolos, to treat myeloma. Panel A shows the chemical structures Glutathione Depletion and Stalwart Anticancer
Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death Frontiers Multi omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma Lipid metabolic vulnerabilities of multiple myeloma Clinical and Experimental Medicine Springer Nature Link
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22



